In 2018, ICP DAS signed a contract with ITRI and obtained TPU technology transfer authorization, and cross-border operation at this time , established the ICP DAS Biomedical Division, entered into the medical-grade thermoplastic polyurethane (TPU) market strongly, and became the first company in Taiwan to produce medical-grade TPU materials. ICP DAS is now ahead of the competition to be able to deploy IIoT systems in smart factories to ensure batch-to-batch consistency in TPU production.
ICP DAS manufactures and provides three series of products, including Alithane™ (ALP series), Durathane™ (ALC series) and Arothane™ (ARP series), which adopt different proportions A wide range of radiopaque fillers that can meet the specific needs of customers. This year, ICP DAS has launched two new products - ARP-B40 and ALC-B40, both loaded with 40% barium sulfate. In addition, sample tubes containing 40%, 60%, 70% and 80% tungsten will also be displayed at the booth of ICP DAS. ICP DAS has a wide range of products that can be widely used in the manufacture of various medical devices, including medical catheters, cardiovascular devices, cancer treatment devices, and guide wire coatings. Application types can be divided into biomedical electronics (electronic respiratory parts), medical equipment (ventricular auxiliary parts, artificial joints), medical consumables (medical catheter guide wires, medical protective clothing, brain catheters, medical optical lens consumables, eye surgery consumables), orthodontics.
Medical-grade TPU needs to pass a number of biocompatibility certifications, and due to its small and diverse characteristics, the threshold for entering this market is relatively high, and long-term determination is required. With the help of ICP DAS' 30 years of industrial Internet of Things technology and experience, ICP DAS Biomedical has built a smart factory to assist in the production and quality management of TPU, and has continuously upgraded and expanded production line equipment to grasp a lasting competitive advantage. ICP DAS maintains the quality consistency and stability of each batch of products. Aiming at the delivery time challenges commonly faced by major medical-grade TPU manufacturers, ICP DAS Biomedical is committed to shortening the delivery time to meet customer needs. Through continuous innovation and research and development, ICP DAS Biomedical has successfully entered the international market with high-stability medical-grade TPU.
微信扫一扫打赏
